Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows

August 2, 2018

(Illustration created using Getty Images)

About Insight

Insight provides an in-depth look at health care issues in and affecting California.

Have a story suggestion? Let us know.

Kaiser Health News reporter Carmen Heredia Rodriguez joins the host of “On Point,” Anthony Brooks, to discuss public health officials’ concerns about the increasing use of the drug gabapentin by people addicted to opioids. Gabapentin is not an opioid, and it is approved to treat patients with nerve pain or epilepsy. However, some people are illicitly buying the drug and abusing it to enhance their opioid highs or stave off withdrawal from other drugs.

Heredia Rodriguez wrote about the problem in an earlier story on KHN.

The “On Point” discussion about the drug (cue it up at 39:22) follows a discussion on the show about proposals for a single-payer health system.

“On Point” is produced by WBUR in Boston and distributed by NPR.

This story was produced by Kaiser Health News, an editorially independent program of the Kaiser Family Foundation.

Copy And Paste To Republish This Story

Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows

August 2, 2018

Article HTML

<h1>Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows</h1><p>	<iframe 
 title="Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows" aria-label="Podcast title: Listen: Inexpensive Nerve Drug Often Abused As Opioid Epidemic Grows"
		id="wpcom-iframe-0249d63306997dcf8cce021eda1e7c1d-7618883-121704370"
		width="100%"
		height="124"
		src="https://embeds.kff.org/protected-iframe/0249d63306997dcf8cce021eda1e7c1d-7618883-121704370"
		scrolling="no"
		frameborder="0"
		class="wpcom-protected-iframe"
		>
	</iframe>
	<script type="text/javascript">
		( function() {
			var func = function() {
				var iframe = document.getElementById('wpcom-iframe-0249d63306997dcf8cce021eda1e7c1d-7618883-121704370')
				if ( iframe ) {
					iframe.onload = function() {
						iframe.contentWindow.postMessage( {
							'msg_type': 'poll_size',
							'frame_id': 'wpcom-iframe-0249d63306997dcf8cce021eda1e7c1d-7618883-121704370'
						}, "https:\/\/embeds.kff.org" );
					}
				}

// Autosize iframe
				var funcSizeResponse = function( e ) {

var origin = document.createElement( 'a' );
					origin.href = e.origin;

// Verify message origin
					if ( 'embeds.kff.org' !== origin.host )
						return;

// Verify message is in a format we expect
					if ( 'object' !== typeof e.data || undefined === e.data.msg_type )
						return;

switch ( e.data.msg_type ) {
						case 'poll_size:response':
							var iframe = document.getElementById( e.data._request.frame_id );

if ( iframe && '' === iframe.width )
								iframe.width = '100%';
							if ( iframe && '' === iframe.height )
								iframe.height = parseInt( e.data.height );

return;
						default:
							return;
					}
				}

if ( 'function' === typeof window.addEventListener ) {
					window.addEventListener( 'message', funcSizeResponse, false );
				} else if ( 'function' === typeof window.attachEvent ) {
					window.attachEvent( 'onmessage', funcSizeResponse );
				}
			}
			if (document.readyState === 'complete') { func.apply(); /* compat for infinite scroll */ }
			else if ( document.addEventListener ) { document.addEventListener( 'DOMContentLoaded', func, false ); }
			else if ( document.attachEvent ) { document.attachEvent( 'onreadystatechange', func ); }
		} )();
		</script>
	
Kaiser Health News reporter <a href="http://www.wbur.org/onpoint/2018/08/02/health-care-sanders-medicare-for-all">Carmen Heredia Rodriguez joins the host of “On Point</a>,” Anthony Brooks, to discuss public health officials’ concerns about the increasing use of the drug gabapentin by people addicted to opioids. Gabapentin is not an opioid, and it is approved to treat patients with nerve pain or epilepsy. However, some people are illicitly buying the drug and abusing it to enhance their opioid highs or stave off withdrawal from other drugs.</p>
<p>Heredia Rodriguez wrote about the problem in an <a href="https://kffhealthnews.org/news/new-on-the-streets-drug-for-nerve-pain-boosts-high-for-opioid-abusers/">earlier story</a> on KHN.</p>
<p>The “On Point” discussion about the drug (cue it up at 39:22) follows a discussion on the show about proposals for a single-payer health system.</p>
<p>“On Point” is produced by WBUR in Boston and distributed by NPR.</p>

We encourage organizations to republish our content, free of charge. Here’s what we ask:

You must credit us as the original publisher, with a hyperlink to our californiahealthline.org site. If possible, please include the original author(s) and “California Healthline” in the byline. Please preserve the hyperlinks in the story.

Have questions? Let us know.

From The California Health Care Foundation

Medi-Cal Medi-Cal Facts and Figures – 2024 Edition

Medi-Cal, California’s Medicaid program, is the state’s health insurance program for Californians with low incomes, including children, people with disabilities, and seniors. Get the latest data on this program, which covers one in three Californians.

Health Policy Survey Health Disparities by Race and Ethnicity in California — 2024 Edition

Disparities among historically marginalized groups in California occur across many demographic categories. This Almanac provides data that show how people of color face barriers in accessing health care, often receive suboptimal treatment, and are most likely to experience poor outcomes in the health care system.

Health Policy Survey The 2024 CHCF California Health Policy Survey

Conducted in fall 2023, this survey collected Californian adults’ opinions and experiences on various health care topics, including mental health, medical debt, racial equity, and more.

Related Topics